Rosiglitazone is a medication used to treat type 2 diabetes. Manufacturers of rosiglitazone use it as the standalone ingredient in drug formulations as well as in combination with other substances, such as metformin and glimepiride. Rosiglitazone suppliers market it in the form of 2mg, 4mg, and 8mg oral tablets. Alternatives to the drug include other thiazolidinedione class medications lobeglitazone and pioglitazone. The developer and earliest manufacturer of rosiglitazone was GlaxoSmithKline, who first introduced it into the market in 1999 under the trade name Avandia. Following patent expiry in 2012, other manufacturers and distributors joined the rosiglitazone market with their formulations. It is currently approved in numerous countries worldwide, including but not limited to China, Mexico, Bangladesh, and Israel. And among the largest manufacturers and suppliers of rosiglitazone in the market are companies GlaxoSmithKline, STADA, and Hengrui Pharma. Rosiglitazone suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified rosiglitazone manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.